Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for lipid-cell variant infiltrating bladder urothelial carcinoma has been reported in the published literature.
No clinical trials have been registered for lipid-cell variant infiltrating bladder urothelial carcinoma.
3 publications have been identified in PubMed for lipid-cell variant infiltrating bladder urothelial carcinoma. Research spans Diagnostic / Biomarker (33%), Review / Meta-Analysis (33%), and Epidemiology / Natural History (33%).
Kraevska E (2025). [PMID: 41003151](https://pubmed.ncbi.nlm.nih.gov/41003151/). *Medical sciences (Basel, Switzerland)*. [Diagnostic / Biomarker]
Attanasio G (2025). [PMID: 40735045](https://pubmed.ncbi.nlm.nih.gov/40735045/). *Frontiers in oncology*. [Review / Meta-Analysis]
Agarwal S (2024). [PMID: 38846211](https://pubmed.ncbi.nlm.nih.gov/38846211/). *Cureus*. [Epidemiology / Natural History]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 4:52 AM UTC